Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist
SEOUL,South Korea,Aug. 28,2024-- Yunovia,a drug R&D subsidiary of Ildong Pharmaceutical Group,announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has cleared the IND ap